Toxic digoxin-drug interactions: The major role of renal p-glycoprotein

Veterinary and Human Toxicology

Volumn 40, Issue 1, 1998, Pages 45-46

  Koren, Gideon ^a   Woodland, Cindy ^a   Ito, Shinya ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMIODARONE; CARDIAC GLYCOSIDE; CIMETIDINE; CYCLOSPORIN; DIGOXIN; DILTIAZEM; GENE PRODUCT; GLYCOPROTEIN P; INULIN; ITRACONAZOLE; MULTIDRUG RESISTANCE PROTEIN; NIFEDIPINE; PHENOBARBITAL; PHENYTOIN; PROPAFENONE; QUINIDINE; QUININE; SPIRONOLACTONE; VERAPAMIL; VINCA ALKALOID;

DRUG ELIMINATION; DRUG PROTEIN BINDING; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; KIDNEY CLEARANCE; KIDNEY TUBULE EXCRETION; REVIEW;

ANTI-ARRHYTHMIA AGENTS; CELLS, CULTURED; CYCLOSPORINE; DIGOXIN; DRUG INTERACTIONS; GLOMERULAR FILTRATION RATE; HUMANS; ITRACONAZOLE; KIDNEY TUBULES; P-GLYCOPROTEIN; QUINIDINE; VERAPAMIL;

CINCHONA PUBESCENS; GLOMERULUS; VINCA;

EID: 0031933911     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Anonymous: The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Croup. N Engl J Med 336: 525-533, 1997.
2. Ellenhorn MJ: Medical Toxicology, 2nd Edition. Williams & Wilkins, Baltimore, MD: 541-549, 1997.
3. Steiness E: Renal tubular secretion of digoxin. Circulation 50: 103-107, 1974.
4. Doering W: Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications. N Engl J Med 301: 400-404, 1979.
5. Pedersen KE, Dorph-Pederson A, Kvidat S et al: The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects. Eur J Clin Pharmacol 22: 123-127, 1982.
6. Nademanee K, Kassman R, Hendrickson J et al : Amiodarone-digoxin interation: Clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol 4: 111-116, 1984.
7. Calvo MV, Martin-Suavez A, Martin Luengo C et al : Interaction between digoxin and propafenone, Ther Drug Monit 11: 10-15, 1989.
8. Robieux I, Dorian P, Klein J et al: The effect of cardiac transplantation and cyclosporine therapy on digoxin Pharmacokinetics. J Clin Pharmacol 32: 338-343, 1992.
9. Keren G, Hesslein PS, MacLeod SM: Digoxin toxicity associated with amiodarone therapy in children. J Pediatr 104: 467-470, 1984.
10. Koren C, Klein J, Ciesbrecht E et al: Effects of quinidine on the renal tubular and biliary transport of digoxin in vivo and in vitro studies in the dog. J Pharmacol Exp Ther 247: 1193-1198, 1988.
11. Ito S, Woodland C, Harper PA et al: P-gp-mediated renal tubular secretion of digoxin: The toxicological significance of the urine-blood barrier model. Life Sci 53: PL 25-B1, 1993.
12. Okamura N, Hinai M,Tanigawara Y et al: Digoxin-cyclosporine A interaction: Modulation of the multidrug transporter P-gp in the kidney. J Pharmacol Exp Ther 266: 1614-1619, 1993.
13. Kartner ND, Evernden-Porelle C: Detection of P-gp in multidrug resistant cell lines by monoclonal antibodies. Nature 316: 820-823, 1985.
14. Gros P, Neriah YP, Croop JM et al: Isolation and expression of a cDNA that confers multidrug resistance. Nature 323: 728-731, 1986.
15. Higgins CF: The ABC of channel regulation. Cell 82: 693-696, 1995.
16. Thiebaut F, Tsuruo T, Hamada H et al: Cellular localization of the multidrug-resistance gene product P-gp in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738, 1987.
17. Sugawara I, Kataoka I, Morishita Y et al: Tissue distribution of P-gp encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48: 1926-1929. 1988.
18. Horio M, Chin KV, Curier SJ et al: Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby Canine Kidney cell epithelia. J Biol Chem 264: 14880-14884, 1089.
19. Tanigawara Y, Okamura N, Hirai M et al: Transport of digoxin by human P-gp expressed in a porcine kidney epithelial cell line (LL C-PK1). J Pharm Exp Ther 263: 840-845, 1992.
20. Evers R, Zaman GJR, van Deemter L et al: Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 97: 1211-1218, 1996.
21. Schinkel AH, Wagenaar E, van Deemter L et al: Absence of the mdrla p-glycoprotein in mice affects tissue distribution and pharmacokientics of dexamethasone, digoxin, and cyclosporin. J Clin Invest 96: 1698-1705, 1995.
22. m of the pump. Biochim Biophys Acta 1027: 116-122, 1990.
23. Pan BF, Dutt A, Nelson JA: Enhanced transep ithelial flux of cimetidine by Madin-Darby canbine kidney cells overexpressing human P-gp. J Pharm Exp Ther 270: 107, 1994.
24. de Lannoy IAM, Silverman M: The MDR1 gene product, P-gp, mediates the transport of the cardiac glycoside, digoxin. Biochem Biophys Res Comm 189: 551-557, 1992.
25. Ito S, Koren C, Harper PA et al: Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1). Can J Physiol Pharmacol 71: 40-47, 1993.
26. Partanen J, Jalavin KM, Neuvonen PJ: Increases serum digoxin concentration, Pharmacol Toxicol 79: 274-276, 1996.
27. Roninson IB: Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum Press, NY 1991.
28. Pedersen K, Lysgaard Madsen J, Klitgaard NA et al: Effect of guinine on plasma digoxin concentration and renal digoxin clearance. Acta Mod Scand 218: 229-232, 1985.
29. Pedersen KE, Madsen JL, Klitgaard NA et al: Non interaction between nifedipine and digoxin. Dan Med Bull 33: 109-110, 1986.
30. Kuhlmann J: Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin. Clin Pharmacol Ther 37: 150-156, 1985.
31. Rameis H: On the interaction between phenytoin and digoxin. Eur J Clin Pharmacol 29: 49-53, 1985.
32. Ravis WR, Pedersoli WM, Turco JD: Pharmacokinetics and interactions of digoxin with phenobarbital in dogs. Am J Vet Res 48: 1244-1249, 1987.
33. Fenster PE, Corness KA, Hanson CD et al : Kinetics of the digoxin-asprin combination. Clin Pharmacol Ther 32: 428-430, 1982.
34. Carty M, Perry C, Shmueli H et al: Effect of cimetidine on digoxin disposition in peptic ulcer patients. Eur J Clin Pharmacol 30: 489-491, 1986.